VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS20066834 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
TVIS20068128 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
TVIS20066130 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
TVIS20020649 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
TVIS20020650 | HPV | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
TVIS44008948 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
TVIS44024155 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
TVIS44035634 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
TVIS44051718 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
TVIS44051719 | HTLV-1 | ENSG00000100030.15 | protein_coding | MAPK1 | Yes | No | 5594 | P28482 Q1HBJ4 Q499G7 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | MAPK1 |
---|---|
DrugBank ID | DB13930 |
Drug Name | Ulixertinib |
Target ID | BE0000923 |
UniProt ID | P28482 |
Regulation Type | inhibitor |
PubMed IDs | 28939558 |
Citations | Germann UA, Furey BF, Markland W, Hoover RR, Aronov AM, Roix JJ, Hale M, Boucher DM, Sorrell DA, Martinez-Botella G, Fitzgibbon M, Shapiro P, Wick MJ, Samadani R, Meshaw K, Groover A, DeCrescenzo G, Namchuk M, Emery CM, Saha S, Welsch DJ: Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib). Mol Cancer Ther. 2017 Nov;16(11):2351-2363. doi: 10.1158/1535-7163.MCT-17-0456. Epub 2017 Sep 22. |
Groups | Investigational |
Direct Classification | |
SMILES | [H]N([C@H](CO)C1=CC(Cl)=CC=C1)C(=O)C1=CC(=CN1[H])C1=CC(=NC=C1Cl)N([H])C(C)C |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL3590106 |